Related Experiment Video
Updated: Jun 26, 2026
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
QTc interval screening in methadone treatment.
Mori J Krantz1, Judith Martin, Barry Stimmel
1Colorado Prevention Center, 789 Sherman Street, Suite 200, Denver, CO 80203, USA.
Physicians should inform patients about cardiac risks associated with methadone. Recommendations include patient screening, QTc interval monitoring, and awareness of drug interactions to ensure cardiac safety.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Methadone, a widely used opioid, carries risks of cardiac arrhythmias.
- Physician awareness of methadone's cardiac effects is crucial for patient safety.
Framework:
- An expert panel developed cardiac safety recommendations for methadone prescribers.
- Recommendations are based on literature reviews, guidelines, and regulatory information.
Implementation:
- Disclose arrhythmia risk to patients.
- Assess patient history for cardiac conditions.
- Obtain baseline and follow-up electrocardiograms (ECGs) to monitor the QTc interval.
- Stratify risk based on QTc interval measurements.
- Be aware of drug interactions that prolong the QTc interval.
Implications:
- These guidelines aim to mitigate cardiac adverse events in patients receiving methadone.
- Proactive cardiac monitoring can improve patient outcomes and reduce methadone-related risks.
Related Concept Videos
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
01:29Therapeutic Drug Monitoring: Affecting Factors
01:16Therapeutic Drug Monitoring: Overview and Classification
01:19Dosage Interval and Administration Route: Determination Methods